Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Immunocore Holdings plc

NASDAQ: IMCR · Life Sciences · 3 alerts · CIK 1671927

Share price
$28.88Close, Nov 16
Market cap
$1.49B
Shares outstanding
51.68MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Immunocore Holdings plc filings on SEC EDGAR ↗

7:15 AM ET 8-K
Business Update

Immunocore Holdings Business Update

Immunocore has achieved its target enrollment of 540 patients in the Phase 3 TEBE-AM clinical trial evaluating tebentafusp (KIMMTRAK) for the treatment of advanced melanoma. The trial is a registrational study, and the company expects to report topline overall survival data as early as the end of 2026.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.